Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Acquisition Adds Strategic Muscle On Manufacturing & Development Side

Go back to Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Acquisition Adds Strategic Muscle On Manufacturing & Development Side